Search research articles
Contact Us
Filters
Showing results (671-680 of 683) with videos related to
Page
of 69
Sort By:
Antimicrobial Agents and Chemotherapy
|
September 30, 2024
Spectinamide MBX-4888A exhibits favorable lesion and tissue distribution and promotes treatment shortening in advanced murine models of tuberculosis
Allison A Bauman, Jansy P Sarathy, Firat Kaya, et al.
Cell
|
July 4, 2017
Development of a Novel Lead that Targets M. tuberculosis Polyketide Synthase 13
Anup Aggarwal, Maloy K Parai, Nishant Shetty, et al.
Database : the Journal of Biological Databases and Curation
|
October 4, 2016
The Global Genome Biodiversity Network (GGBN) Data Standard specification
G Droege, K Barker, O Seberg, et al.
Antimicrobial Agents and Chemotherapy
|
May 24, 2022
GSK2556286 Is a Novel Antitubercular Drug Candidate Effective <i>In Vivo</i> with the Potential To Shorten Tuberculosis Treatment
Eric L Nuermberger, Maria Santos Martínez-Martínez, Olalla Sanz, et al.
ACS Infectious Diseases
|
April 6, 2024
Mtb-Selective 5-Aminomethyl Oxazolidinone Prodrugs: Robust Potency and Potential Liabilities
Helena I M Boshoff, Katherine Young, Yong-Mo Ahn, et al.
Nature Communications
|
October 22, 2025
The role of cytochrome bc<sub>1</sub> inhibitors in future tuberculosis treatment regimens
Clara Aguilar-Pérez, Anne J Lenaerts, Cristina Villellas, et al.
ACS Omega
|
February 1, 2021
Spirocycle MmpL3 Inhibitors with Improved hERG and Cytotoxicity Profiles as Inhibitors of <i>Mycobacterium tuberculosis</i> Growth
Peter C Ray, Margaret Huggett, Penelope A Turner, et al.
Journal of Medicinal Chemistry
|
December 15, 2021
Optimization of TAM16, a Benzofuran That Inhibits the Thioesterase Activity of Pks13; Evaluation toward a Preclinical Candidate for a Novel Antituberculosis Clinical Target
Caroline Wilson, Peter Ray, Fabio Zuccotto, et al.
Nature Communications
|
May 19, 2021
Mycobacterium tuberculosis precursor rRNA as a measure of treatment-shortening activity of drugs and regimens
Nicholas D Walter, Sarah E M Born, Gregory T Robertson, et al.
Nature
|
July 31, 2025
SuFEx-based antitubercular compound irreversibly inhibits Pks13
Inna V Krieger, Paridhi Sukheja, Baiyuan Yang, et al.
Page
of 69
Search research articles
Search
Showing results (671-680 of 683) with videos related to
Sort By:
Page
of 69
Antimicrobial Agents and Chemotherapy
|
September 30, 2024
Spectinamide MBX-4888A exhibits favorable lesion and tissue distribution and promotes treatment shortening in advanced murine models of tuberculosis
Allison A Bauman, Jansy P Sarathy, Firat Kaya, et al.
Cell
|
July 4, 2017
Development of a Novel Lead that Targets M. tuberculosis Polyketide Synthase 13
Anup Aggarwal, Maloy K Parai, Nishant Shetty, et al.
Database : the Journal of Biological Databases and Curation
|
October 4, 2016
The Global Genome Biodiversity Network (GGBN) Data Standard specification
G Droege, K Barker, O Seberg, et al.
Antimicrobial Agents and Chemotherapy
|
May 24, 2022
GSK2556286 Is a Novel Antitubercular Drug Candidate Effective <i>In Vivo</i> with the Potential To Shorten Tuberculosis Treatment
Eric L Nuermberger, Maria Santos Martínez-Martínez, Olalla Sanz, et al.
ACS Infectious Diseases
|
April 6, 2024
Mtb-Selective 5-Aminomethyl Oxazolidinone Prodrugs: Robust Potency and Potential Liabilities
Helena I M Boshoff, Katherine Young, Yong-Mo Ahn, et al.
Nature Communications
|
October 22, 2025
The role of cytochrome bc<sub>1</sub> inhibitors in future tuberculosis treatment regimens
Clara Aguilar-Pérez, Anne J Lenaerts, Cristina Villellas, et al.
ACS Omega
|
February 1, 2021
Spirocycle MmpL3 Inhibitors with Improved hERG and Cytotoxicity Profiles as Inhibitors of <i>Mycobacterium tuberculosis</i> Growth
Peter C Ray, Margaret Huggett, Penelope A Turner, et al.
Journal of Medicinal Chemistry
|
December 15, 2021
Optimization of TAM16, a Benzofuran That Inhibits the Thioesterase Activity of Pks13; Evaluation toward a Preclinical Candidate for a Novel Antituberculosis Clinical Target
Caroline Wilson, Peter Ray, Fabio Zuccotto, et al.
Nature Communications
|
May 19, 2021
Mycobacterium tuberculosis precursor rRNA as a measure of treatment-shortening activity of drugs and regimens
Nicholas D Walter, Sarah E M Born, Gregory T Robertson, et al.
Nature
|
July 31, 2025
SuFEx-based antitubercular compound irreversibly inhibits Pks13
Inna V Krieger, Paridhi Sukheja, Baiyuan Yang, et al.
Page
of 69